Researchers locate master cutoff switch for cancer-causing HER2 protein

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.

Advancing the knowledge of ALS and FTD

Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.

Mayo Clinic Researchers Classify Obesity To Improve Treatment

Andres Acosta, M.D., Ph.D, a Mayo Clinic gastroenterologist, discusses a recent study associating certain traits with obesity.

The Pharmacokinetics Core: A resource for translational science innovation and drug development

Joel M. Reid, Ph.D, presents The Pharmacokinetics Core: A Resource for Translational Science Innovation and Drug Development.

Instrumenting the Health Care Enterprise for Discovery Science

Dr. Murphy presents Instrumenting the Health Care Enterprise for Discovery Science

Dissecting Diagnostic Odyssey Cases in the Era of Precision Medicine

Dr. Konstantinos presents Dissecting Diagnostic Odyssey Cases in the Era of Precision Medicine